MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-PB-01-0013735
Apellon Biotech Private Limited - pharma in Amritsar, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.05 Cr
▲ 2% YoY
Net profit · FY 2025
₹58.96 Lakh
Net margin 4.5%
EBITDA · FY 2025
₹96.07 Lakh
EBITDA margin 7.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.2 Lakh
Issued & subscribed
Open charges
₹1.4 Cr
Satisfied ₹15 Lakh
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
About Apellon Biotech Private Limited
Data last updated:
Apellon Biotech Private Limited is a private limited company based in Amritsar, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2014PTC038266. Its GSTIN is 03AAMCA3358A1Z5 (Punjab).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors including Nikita Marwaha and Dinesh Kumar.
Its last annual general meeting (AGM) was held on 29 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Maa Complex Shop No.2 & 4 Nagina Avenue Majitha Road, Amritsar, Punjab, India – 143001.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.05 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹58.96 Lakh (net margin 4.5%) and EBITDA of ₹96.07 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹1.4 Cr and satisfied charges of ₹15 Lakh on record.
Apellon Biotech Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-PB-01-0013735). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apellon.net.
Company Details of Apellon Biotech Private Limited
CIN U24232PB2014PTC038266
Registration Number 038266
Incorporation Date 08 January 2014
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 November 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-PB-01-0013735
Recognitions & Rankings of Apellon Biotech
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressMaa Complex Shop No.2 & 4 Nagina Avenue Majitha Road, Amritsar, Punjab, India – 143001
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Apellon Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Apellon Biotech Private Limited
The main business activity of Apellon Biotech is manufacturing. In detail, this covers food, beverages and tobacco products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C1 | Food, beverages and tobacco products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Apellon Biotech Private Limited FY 2025 filings available
Apellon Biotech Private Limited reported revenue of ₹13.05 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹13.05 Cr ▲ 2%
Net profit · FY 2025
₹58.96 Lakh margin 4.5%
EBITDA · FY 2025
₹96.07 Lakh margin 7.4%
Compounded Annual Growth Rate (CAGR) of Apellon Biotech Private Limited
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 11%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 36%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 2% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Apellon Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹96.07 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹58.96 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Apellon Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Apellon Biotech are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Apellon Biotech Private Limited
Apellon Biotech has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikita Marwaha | Director | 08 Jan 2014 | 12 Years 9 Months | Current |
| Dinesh Kumar Also directs: Apellon Healthcare Private Limited | Director | 08 Jan 2014 | 12 Years 9 Months | Current |
| Indu Gupta Also directs: Aradhia Pharmaceuticals India Private Limited | Director | 08 Jan 2014 | 12 Years 9 Months | Current |
Peer Comparison of Apellon Biotech Private Limited
Apellon Biotech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kaps Three Life Sciences Private Limited | ₹13.11 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Surendranagar, Gujarat, India |
| Merit Polychem Pvt. Ltd. | ₹13.11 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Kolkata, West Bengal, India |
| Guided Gateway Private Limited | ₹13.1 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Sankrail, West Bengal, India |
| Amegh Pharma Private Limited | ₹13.09 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Mumbai, Maharashtra, India |
| Graceplus Healthcare Private Limited | ₹13.07 Cr (FY 2025) | •••• | •••• | 203.0% | •••• | Delhi, India |
| Apellon Biotech Private Limited this company | ₹13.05 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Amritsar, Punjab, India |
| Chandroday Sales & Services Pvt Ltd | ₹13.05 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Kolkata, West Bengal, India |
| Theraoral Care Products Private Limited | ₹13.05 Cr (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Embee Healthcare Private Limited | ₹13.05 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | New Delhi, Delhi, India |
| Aurora Nutraceuticals Private Limited | ₹13.05 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
| Novacel Therapeutics Private Limited | ₹13.03 Cr (FY 2020) | •••• | •••• | -27.0% | •••• | Guntur, Andhra Pradesh, India |
Peers are the five companies nearest above and the five nearest below Apellon Biotech by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Apellon Biotech Private Limited
Apellon Biotech Private Limited is audited by ARORA AGGARWAL & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARORA AGGARWAL & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Apellon Biotech Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Apellon Biotech Private Limited
Open charges
₹1.4 Cr
Satisfied charges
₹15 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2025 | Hdfc Bank Limited | ₹8.2 Lakh | Open |
| 23 May 2025 | Hdfc Bank Limited | ₹66 Lakh | Open |
| 19 Apr 2023 | Hdfc Bank Limited | ₹15.75 Lakh | Open |
| 10 May 2016 | Hdfc Bank Limited | ₹50 Lakh | Open |
| 08 Jan 2015 | State Bank of India | ₹15 Lakh | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Apellon Biotech Private Limited
Employment history and EPFO contributions of people linked to Apellon Biotech.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Apellon Biotech Private Limited
Apellon Biotech Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Dinesh Kumar was appointed as Director on 08 Jan 2014.
AGM
Apellon Biotech Private Limited last Annual general meeting of members was held on 29 Nov 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.20 Lakh with Charge ID 101176420 was registered on 21 Oct 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 66.00 Lakh with Charge ID 101104543 was registered on 23 May 2025.
Filing
Apellon Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.75 Lakh with Charge ID 100709781 was registered on 19 Apr 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 50.00 Lakh registered on 10 May 2016 with Charge ID 100042215 was modified on 16 May 2017.
Charges
A charge registered on 08 Jan 2015 via Charge ID 10542512 with State Bank Of India was fully satisfied on 13 Feb 2017.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 100042215 was registered on 10 May 2016.
Charges
A charge with State Bank Of India amounted to Rs. 15.00 Lakh with Charge ID 10542512 was registered on 08 Jan 2015.
Appointed
Dinesh Kumar was appointed as Director.
Appointed
Indu Gupta was appointed as Director.
Appointed
Nikita Marwaha was appointed as Director.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Apellon Biotech Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apellon Biotech Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apellon Biotech Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Apellon Biotech Private Limited
Apellon Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAMCA3358A1Z5 | Punjab | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apellon Biotech Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apellon Biotech Private Limited
Apellon Biotech is an active private limited company based in Amritsar, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 January 2014 (12+ years old) and is registered under CIN U24232PB2014PTC038266.
Apellon Biotech reported revenue of ₹13.05 Cr for FY 2025 (up 2% YoY).
Apellon Biotech has 3 current directors:
- Nikita Marwaha - Director
- Dinesh Kumar - Director
- Indu Gupta - Director
Apellon Biotech reported a net profit of ₹58.96 Lakh (net margin 4.5%) and EBITDA of ₹96.07 Lakh (EBITDA margin 7.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Apellon Biotech is 11% over three years and 11% over five years. In the latest year (FY 2025) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Apellon Biotech is 03AAMCA3358A1Z5, registered in Punjab.
The CIN (Corporate Identification Number) of Apellon Biotech is U24232PB2014PTC038266. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apellon Biotech was incorporated on 08 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Apellon Biotech by revenue are Kaps Three Life Sciences Private Limited, Merit Polychem Pvt. Ltd, Guided Gateway Private Limited, Amegh Pharma Private Limited, Graceplus Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Dinesh Kumar was appointed as Director on 08 Jan 2014. Indu Gupta was appointed as Director on 08 Jan 2014. Nikita Marwaha was appointed as Director on 08 Jan 2014.
Yes, Apellon Biotech is registered as an MSME under Udyam registration (number: UDYAM-PB-01-0013735).